Figure 1‑1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Share Ranking by Segment, Global, 2021 (1 of 2) |
Figure 1‑2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Share Ranking by Segment, Global, 2021 (2 of 2) |
Figure 1‑3: Companies Researched in this Report |
Figure 1‑4: Factors Impacting the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Global (1 of 2) |
Figure 1‑5: Factors Impacting the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Global (2 of 2) |
Figure 1‑6: Recent Events in the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, Global, 2018 – 2022 (1 of 2) |
Figure 1‑7: Recent Events in the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, Global, 2018 – 2022 (2 of 2) |
Figure 1‑8: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures Covered |
Figure 1‑9: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Markets Covered (1 of 2) |
Figure 1‑10: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Markets Covered (2 of 2) |
Figure 1‑11: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Regions Covered, Global (1 of 2) |
Figure 1‑12: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Regions Covered, Global (2 of 2) |
Figure 1‑13: Version History |
Figure 2‑1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Worst Case Scenario, Global, 2018 – 2028 (US$M) |
Figure 2‑2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Base Case Scenario, Global, 2018 – 2028 (US$M) |
Figure 2‑3: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Best Case Scenario, Global, 2018 – 2028 (US$M) |
Figure 4‑1: Pacemaker Market Products by Company |
Figure 4‑2: ICD Market Products by Company |
Figure 4‑3: CRT Device Market Products by Company (1 of 2) |
Figure 4‑4: CRT Device Market Products by Company (2 of 2) |
Figure 4‑5: Cardiac Lead Market Products by Company |
Figure 4‑6: Implantable Loop Recorder Market Products by Company |
Figure 4‑7: EP Lab System Market Products by Company |
Figure 4‑8: Diagnostic EP Catheter Market Products by Company |
Figure 4‑9: Cardiac Ablation Catheter Products by Company (1 of 2) |
Figure 4‑10: Cardiac Ablation Catheter Products by Company (2 of 2) |
Figure 4‑11: Class 1 Device Recall Assurity pacemakers |
Figure 4‑12: Class 1 Device Recall St. Jude Endurity Pacemakers |
Figure 4‑13: Class 1 Device Recall Fortify, Unify, Assura, including Quadra |
Figure 4‑14: Class 2 Device Recall Ellipse |
Figure 4‑15: Class 2 Device Recall Quadra Assura |
Figure 4‑16: Class 2 Device Recall Unify Assura |
Figure 4‑17: Class 2 Device Recall Unify Quadra |
Figure 4‑18: Class 2 Device Recall Promote Quadra |
Figure 4‑19: Class 2 Device Recall Allure Quadra |
Figure 4‑20: Class 2 Device Recall Allure Quadra |
Figure 4‑21: Class 2 Device Recall Anthem, Allure |
Figure 4‑22: Class 2 Device Recall Nuance |
Figure 4‑23: Class 1 Device Recall Optisure HV lead |
Figure 4‑24: Class 2 Device Recall FIRMap |
Figure 4‑25: Class 2 Device Recall WorkMate Claris, v.1.2 Upgrade Kits |
Figure 4‑26: Class 3 Device Recall FIRMap 60mm Catheter |
Figure 4‑27: Class 2 Device Recall Abbott |
Figure 4‑28: Class 2 Device Recall TactiSys Quartz Pack, PN004 400 |
Figure 4‑29: Class 2 Device Recall CARTO 3 System |
Figure 4‑30: Class 2 Device Recall SMARTABLATE RF Generator System |
Figure 4‑31: Class 2 Device Recall ACUSON AcuNav Volume ICE Catheter |
Figure 4‑32: Class 2 Device Recall PENTARAY NAV eco HighDensity Mapping Catheter |
Figure 4‑33: Class 2 Device Recall PENTARAY NAV HighDensity Mapping Catheter |
Figure 4‑34: Class 2 Device Recall SOUNDSTAR eco Catheter |
Figure 4‑35: Class 2 Device Recall WEBSTER Fixed Curve Catheter with Auto ID Technology |
Figure 4‑36: Class 2 Device Recall THERMOCOOL SMARTTOUCH |
Figure 4‑37: Class 1 Device Recall ADVANTIO DR EL |
Figure 4‑38: Class 1 Device Recall INGENIO DR EL |
Figure 4‑39: Class 1 Device Recall VITALIO DR EL |
Figure 4‑40: Class 2 Device Recall Accolade |
Figure 4‑41: Class 2 Device Recall Essentio |
Figure 4‑42: Class 2 Device Recall EMBLEM |
Figure 4‑43: Class 1 Device Recall EMBLEM |
Figure 4‑44: Class 2 Device Recall ESSENTIO Pacemaker |
Figure 4‑45: Class 2 Device Recall PROPONENT Pacemaker |
Figure 4‑46: Class 2 Device Recall ACCOLADE Pacemaker |
Figure 4‑47: Class 2 Device Recall ACCOLADE MRI Pacemaker |
Figure 4‑48: Class 2 Device Recall ESSENTIO MRI Pacemaker |
Figure 4‑49: Class 2 Device Recall ESSENTIO Pacemaker |
Figure 4‑50: Class 2 Device Recall PROPONENT Pacemaker |
Figure 4‑51: Class 2 Device Recall PROPONENT MRI Pacemaker |
Figure 4‑52: Class 2 Device Recall ALTRUA 2 EL DR Pacemaker |
Figure 4‑53: Class 2 Device Recall ALTRUA 2 SR Pacemaker |
Figure 4‑54: Class 2 Device Recall ALTRUA 2 DR Pacemaker |
Figure 4‑55: Class 2 Device Recall Accolade MRI and Essentio MRI pacemakers |
Figure 4‑56: Class 2 Device Recall EMBLEM |
Figure 4‑57: Class 2 Device Recall EMBLEM |
Figure 4‑58: Class 1 Device Recall EMBLEM |
Figure 4‑59: Class 2 Device Recall DYNAGEN EL ICD DR |
Figure 4‑60: Class 2 Device Recall Implantable Cardioverter Defibrillator (NonCRT) |
Figure 4‑61: Class 2 Device Recall RESONATE EL ICD VR/DR |
Figure 4‑62: Class 2 Device Recall EMBLEM SICD, Model A209 |
Figure 4‑63: Class 2 Device Recall SQRX 1010 Pulse Generator |
Figure 4‑64: Class 2 Device Recall EMBLEM MRI SICD Model 219 |
Figure 4‑65: Class 2 Device Recall SQRX Model 1010 Subcutaneous Pulse Generator |
Figure 4‑66: Class 1 Device Recall INTUA CRTP |
Figure 4‑67: Class 1 Device Recall INVIVE CRTP |
Figure 4‑68: Class 2 Device Recall VISIONIST CRTP |
Figure 4‑69: Class 2 Device Recall VALITUDE CRTP |
Figure 4‑70: Class 2 Device Recall VALITUDE X4 CRTP (Cardiac Resynchronization Therapy Pacemaker) |
Figure 4‑71: Class 2 Device Recall VALITUDE X4 CRTP Pacemaker |
Figure 4‑72: Class 2 Device Recall VALITUDE CRTP Pacemaker |
Figure 4‑73: Class 2 Device Recall VISIONIST X4 CRTP Pacemaker |
Figure 4‑74: Class 2 Device Recall VISIONIST CRTP Pacemaker |
Figure 4‑75: Class 2 Device Recall RESONATE X4 CRTD |
Figure 4‑76: Class 2 Device Recall MOMENTUM X4 CRTD |
Figure 4‑77: Class 2 Device Recall VIGILANT X4 CRTD |
Figure 4‑78: Class 2 Device Recall Boston Scientific, INGEVITY MRI Leads, Sterile EO, RxOnly |
Figure 4‑79: Class 2 Device Recall iLab Polaris MultiModality Guidance System |
Figure 4‑80: Class 2 Device Recall Maestro 4000 Cardiac Ablation System |
Figure 4‑81: Class 2 Device Recall CLEARSIGN II Amplifier for LABSYSTEM PRO EP Recording System |
Figure 4‑82: Class 3 Device Recall Cardiac Ablation Percutaneous Catheters |
Figure 4‑83: Class 1 Device Recall Intella Tip MiFi Open Irrigated Ablation Catheter |
Figure 4‑84: Class 2 Device Recall Astra XT DR Implantable pulse generator |
Figure 4‑85: Class 2 Device Recall Azure |
Figure 4‑86: Class 2 Device Recall Azure XT DR MRI |
Figure 4‑87: Class 2 Device Recall Azure S DR MRI |
Figure 4‑88: Class 2 Device Recall Azure XT SR MRI |
Figure 4‑89: Class 2 Device Recall Azure S SR MRI |
Figure 4‑90: Class 2 Device Recall Medtronic Micra MC1VR01 |
Figure 4‑91: Class 1 Device Recall SPHERA, Dual chamber pacemaker |
Figure 4‑92: Class 1 Device Recall SENSIA, Dual chamber pacemaker |
Figure 4‑93: Class 1 Device Recall VERSA, Dual chamber pacemaker |
Figure 4‑94: Class 1 Device Recall ADAPTA, Dual chamber pacemaker |
Figure 4‑95: Class 1 Device Recall ATTESTA L DR MRI SureScan, Dual chamber rate responsive pacemaker |
Figure 4‑96: Class 2 Device Recall Medtronic Model 53401 Single Chamber External Pulse Generator |
Figure 4‑97: Class 2 Device Recall Medtronic Model 5392 Dual Chamber Temporary External Pulse Generator |
Figure 4‑98: Class 1 Device Recall Cobalt |
Figure 4‑99: Class 1 Device Recall Crome |
Figure 4‑100: Class 1 Device Recall Evera and Visia |
Figure 4‑101: Class 2 Device Recall EnTrust Dual Chamber Implantable Cardioverter Defibrillator with Atrial and Ventricular Therapies |
Figure 4‑102: Class 2 Device Recall EnTrust Single Chamber Implantable Cardioverter Defibrillator with Atrial and Ventricular Therapies |
Figure 4‑103: Class 2 Device Recall Medtronic EnTrust Escudo |
Figure 4‑104: Class 1 Device Recall Evera MRI XT DR ICD, Evera MRI XT VR ICD, Evera MRI S DR ICD |
Figure 4‑105: Class 1 Device Recall Visia AF MRI VR SureScan ICD |
Figure 4‑106: Class 1 Device Recall Visia AF VR ICD |
Figure 4‑107: Class 1 Device Recall Evera S DR ICD, Evera S VR ICD, Evera XT DR ICD, Evera XT VR ICD |
Figure 4‑108: Class 2 Device Recall Evera ICD |
Figure 4‑109: Class 2 Device Recall Viva ICD |
Figure 4‑110: Class 1 Device Recall Cobalt |
Figure 4‑111: Class 1 Device Recall Crome |
Figure 4‑112: Class 2 Device Recall Cobalt |
Figure 4‑113: Class 2 Device Recall Precepta |
Figure 4‑114: Class 2 Device Recall Percepta, Serena, and Solara CRTP MRI |
Figure 4‑115: Class 1 Device Recall Viva, Claria, Amplia, Compia, and Brava |
Figure 4‑116: Class 2 Device Recall Percepta CRTP MRI |
Figure 4‑117: Class 2 Device Recall Solara CRTP MRI |
Figure 4‑118: Class 2 Device Recall Serena CRTP MRI |
Figure 4‑119: Class 2 Device Recall Percepta CRTP MRI SureScan |
Figure 4‑120: Class 2 Device Recall Percepta Quad CRTP MRI SureScan |
Figure 4‑121: Class 1 Device Recall Amplia MRI CRTD, Amplia MRI Quad CRTD |
Figure 4‑122: Class 1 Device Recall Viva Quad S CRTD, Viva Quad XT CRTD, Viva S CRTD, Viva XT CRTD |
Figure 4‑123: Class 1 Device Recall Compia MRI CRTD, Compia MRI Quad CRTD |
Figure 4‑124: Class 2 Device Recall Amplia MRI Quad CRT0 SureScanClaria MRI Quad CRTD SureScanCompia MRI Quad CRTD SureScan |
Figure 4‑125: Class 2 Device Recall InSync III |
Figure 4‑126: Class 2 Device Recall Sprint Quattro |
Figure 4‑127: Class 2 Device Recall Medtronic, Temporary Pacing Lead System |
Figure 4‑128: Class 2 Device Recall Achieve Electrical Cable |
Figure 4‑129: Class 2 Device Recall Medtronic CryoConsole |
Figure 4‑130: Class 2 Device Recall Platinium Implantable Cardiac Defibrillator and Resynchronization Therapy Defibrillator |
Figure 4‑131: Class 2 Device Recall Platinium DR 1510 |
Figure 4‑132: Class 2 Device Recall Platinium VR 1210 |
Figure 4‑133: Class 2 Device Recall Platinium DR DF4 1540 |
Figure 4‑134: Class 2 Device Recall Platinium VR DF4 1240 |
Figure 4‑135: Class 2 Device Recall PARADYM |
Figure 4‑136: Class 2 Device Recall OVATIO |
Figure 4‑137: Class 2 Device Recall INTENSIA |
Figure 4‑138: Class 2 Device Recall Platinium Implantable Cardiac Defibrillator and Resynchronization Therapy Defibrillator |
Figure 4‑139: Class 2 Device Recall Platinium CRTD 1741 |
Figure 4‑140: Class 2 Device Recall Platinium CRT DF1 1711 |
Figure 4‑141: Class 2 Device Recall PARADYM |
Figure 4‑142: Class 2 Device Recall OVATIO |
Figure 4‑143: Class 2 Device Recall INTENSIA |
Figure 4‑144: The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System |
Figure 4‑145: Aveir VR Coverage With Evidence Development Post-Approval Study (CED) |
Figure 4‑146: A Retrospective Trial to Evaluate the Micra Pacemaker (Micra) |
Figure 4‑147: Project My Heart Your Heart: Pacemaker Reuse (MHYH) |
Figure 4‑148: Evaluation of Atrial Fibrillation Occurrence in Sick Sinus and Complete Atrioventricular Block Patients After Pacemaker Implantation (AF-pacemaker Study) |
Figure 4‑149: Longitudinal Coverage With Evidence Development Study on Micra Leadless Pacemakers |
Figure 4‑150: Heart Failure Indication and Sudden Cardiac Death Prevention Trial Japan |
Figure 4‑151: BIO|MASTER.Edora Family Study |
Figure 4‑152: China Micra Transcatheter Pacing Study |
Figure 4‑153: Optimizing Pacemaker Therapy Using Multi-Point Pacing (the OPT-MPP Study) |
Figure 4‑154: Electrical Cardioversion, Ablation or Pace and Ablate for Persistent Atrial Fibrillation - The CAPAPAF-65 Study |
Figure 4‑155: Advanced Bradycardia Device Feature Utilization and Clinical Outcomes II |
Figure 4‑156: Observation of ImageReady™ MR Conditional Pacing System in China |
Figure 4‑157: Micra Transcatheter Pacing System Continued Access Study Protocol |
Figure 4‑158: Extravascular ICD Pivotal Study (EV ICD) |
Figure 4‑159: Defibrillation Testing During Implantable Cardioverter Defibrillator (ICD) Replacement (T-DEF) |
Figure 4‑160: Master Study of the Acticor/Rivacor ICDs/CRT-Ds and the Plexa ProMRI S DX Lead |
Figure 4‑161: A Post-market Clinical Evaluation of St. Jude Medical™ MR Conditional ICD System on Patients Undergoing Magnetic Resonance Imaging (ASIA MRI ICD) |
Figure 4‑162: Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycardia Pacing (MODULAR ATP) |
Figure 4‑163: Acute Feasibility Investigation of a New S-ICD Electrode (ASE) |
Figure 4‑164: Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) |
Figure 4‑165: A PRospective, rAndomizEd Comparison of subcuTaneOous and tRansvenous ImplANtable Cardioverter Defibrillator Therapy (PRAETORIAN) |
Figure 4‑166: Comparison of CRT-D and CRT-DX Systems (CRT-NEXT) |
Figure 4‑167: Increasing Detection of Sub-Clinical Atrial Fibrillation in Defibrillator Patients with the Use of a VDD-ICD Lead (Dx-AF) |
Figure 4‑168: Multicenter Automatic Defibrillator Implantation Trial with Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD) |
Figure 4‑169: Extravascular ICD Pilot Study |
Figure 4‑170: Acute Feasibility Investigation of a New S-ICD Electrode |
Figure 4‑171: Subcutaneous ICD Therapy Combined with VT Ablation for the Secondary Prevention of Sudden Cardiac Death |
Figure 4‑172: BIO|MASTER.Ilivia Family/Plexa |
Figure 4‑173: Metabolic Mapping and Cardiac Resynchronization |
Figure 4‑174: CRT-P or CRT-D in Dilated Cardiomyopathy (CRT-REALITY) |
Figure 4‑175: Safety and Performance Aspects of CRT-DX System in Patients with Sinus Rhythm (BIO|REDUCE) |
Figure 4‑176: Prospective Randomized Trial Comparing TRIPLE Site ventricular Stimulation Versus Conventional Pacing in CRT candidates: TRIPLEAD Trial |
Figure 4‑177: Re-evaluation of Optimal Re-synchronization Therapy in Patients with Chronic Heart Failure |
Figure 4‑178: The His Optimised Pacing Evaluated for Heart Failure Trial (HOPE-HF) |
Figure 4‑179: Cardiac Resynchronisation Therapy Versus Rate-responsive Pacing in Heart Failure With Preserved Ejection Fraction (PREFECTUS) |
Figure 4‑180: Cardiac Resynchronization in the Elderly |
Figure 4‑181: Standard Care Versus Triventricular Pacing in Heart Failure (STRIVE HF) |
Figure 4‑182: Responders and Quadripolar LV Lead in CRT |
Figure 4‑183: Does Electric Targeted LV Lead Positioning Improve Outcome in Patients With Heart Failure and Prolonged QRS |
Figure 4‑184: SD01 Master Study (Safety and Efficacy Study) |
Figure 4‑185: Assessment of the Axone Micro Quadripolar Lead for Enhanced Cardiac Resynchronization Therapy (ASTRAL-4LV) |
Figure 4‑186: Safety and Performance of INVICTA Ventricular DF4 LEADS With Active Fixation-(APOLLO) |
Figure 4‑187: Safety and Electrical Performance Evaluation of INVICTA Leads Models Equipped With DF4 Connector (FRIENDS) |
Figure 4‑188: Safety and Electrical Performances Evaluation of Navigo Leads Equipped with IS4 Connector (NAVIGATOR) |
Figure 4‑189: Avoid Transvenous Leads in Appropriate Subjects |
Figure 4‑190: Left Ventricular Septal Pacing: Potential Application for Cardiac Resynchronization Therapy |
Figure 4‑191: Quartet Lead and Resynchronization Therapy Options |
Figure 4‑192: Attain Stability™ Quad Clinical Study |
Figure 4‑193: The Efficacy of Single Coil Defibrillation Leads for Internal Cardioversion of Persistent Atrial Fibrillation |
Figure 4‑194: Reverse RAMP Pacing to Terminate Ventricular Tachycardia (REV-RAMP) |
Figure 4‑195: AXONE -Acute: Acute Assessment of a Micro Multipolar Lead for Enhanced Cardiac Resynchronization Therapy |
Figure 4‑196: A Clinical Evaluation of the Durata or Optisure High Voltage Leads and Ellipse VR ICD Undergoing MRI, an Investigational Device Exemption (IDE) Study |
Figure 4‑197: Acute Study to Collect Electrical Signals From the Heart Using a Special Lead |
Figure 4‑198: RHYTHMIA vs CARTO in Redo Ablation Procedures for Atrial Fibrillation (MAP-AF) |
Figure 4‑199: RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY) |
Figure 4‑200: Cryoballoon vs. Rhythmia Guided Ablation for Recurrent AFib |
Figure 4‑201: Esophageal 3D Mapping System for Cardiac Arrhythmias |
Figure 4‑202: The Basel CardioInsightTM - 3D Mapping Study (BigMap) |
Figure 4‑203: Non-Invasive 3D Mapping for Identifying Origin and Preferential Propagation of Ventricular Arrhythmias |
Figure 4‑204: RADAR Clinical Trial |
Figure 4‑205: EnSite™ HD Grid Catheter Mapping Study |
Figure 4‑206: Clinical Utility and Validation of the Rhythmia Mapping System for the Treatment of Cardiac Arrhythmias |
Figure 4‑207: Surface ECG Signal Recording for the Implantable Subcutaneous String Defibrillator (ISSD) Detection Algorithm Performance Assessment |
Figure 4‑208: An Evaluation of the Safety and Performance of the CathVision Cube® System |
Figure 4‑209: The Automated Calculation of AF Cycle Length and Complexity Using a Novel EP Recording System |
Figure 4‑210: Surface Electrocardiogram (ECG) Signal Recording for Implantable Subcutaneous String Defibrillator (ISSD) Development |
Figure 4‑211: Advanced Cardiac Therapeutics DiamondTemp TempeRAture-Controlled and Contact Sensing RF Ablation Clinical Trial for Atrial Fibrillation |
Figure 4‑212: ICE Based Atrial Flutter Ablation Vs Conventional Fluoroscopy/Anatomical Mapping Based Ablation - ICE Flutter Study |
Figure 4‑213: Philips Intracardiac Echocardiography (ICE) Clinical Registry |
Figure 4‑214: Foresight Intracardiac Echocardiography (ICE) System |
Figure 4‑215: INtra-procedural ultraSound Imaging During Isolation of the Pulmonary Veins |
Figure 4‑216: EnSite Precision™ 2.0 Registry |
Figure 4‑217: Foresight Intracardiac Echocardiography (ICE) System |
Figure 4‑218: EPICADIA - Electrophysiologic Performance Investigation for CArdiac DIAgnosis |
Figure 4‑219: Esophageal 3D Mapping System for Cardiac Arrhythmias: esoECG-3D |
Figure 4‑220: EnSite™ HD Grid Catheter Mapping System for Advanced High Density Three-Dimensional Mapping in Non-Paroxysmal Atrial Fibrillation and Atrial Tachycardia |
Figure 4‑221: DURABLE-I Study: Dielectric Unravelling of Radiofrequency ABLation Effectiveness |
Figure 4‑222: FIRE AND ICE II Trial Pilot |
Figure 4‑223: TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study (TactiCathPAS) |
Figure 4‑224: Abbott Atrial Fibrillation Post Approval Study |
Figure 4‑225: Cryotherapy Versus Radiofrequency Catheter Ablation Research Program |
Figure 4‑226: Safety and Effectiveness Evaluation of the Multi-Electrode Radiofrequency Balloon Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation (STELLAR) |
Figure 4‑227: Clinical Evaluation of the StablePoint Catheter and Force Sensing System for Paroxysmal Atrial Fibrillation (NEwTON AF) |
Figure 4‑228: Clinical Study for Safety and Acute Performance Evaluation of the THERMOCOOL SMARTTOUCH® SF-5D System Used With Fast Ablation Mode in Treatment of Patients With Paroxysmal Atrial Fibrillation |
Figure 4‑229: Comparison of Contact-force Monitoring Irrigated Tip Catheter and Mesh-like Irrigated Tip Catheter in Atrial Fibrillation Ablation: Prospective Randomized Trial (COMMIC Trial) |
Figure 4‑230: Microfidelity (MIFI) Ablation Technology Versus Standard Ablation Catheter for Atrioventricular Nodal Ablation A Comparative Pilot Study of Time to Success |
Figure 4‑231: Cardiovascular Magnetic Resonance-Guided Radiofrequency-Ablation for Atrial Flutter |
Figure 4‑232: Advanced Cardiac Therapeutics DiamondTemp TempeRAture-Controlled and Contact Sensing RF Ablation Clinical Trial for Atrial Fibrillation |
Figure 4‑233: CRyoAblation vs AntiaRrhythmic Drugs for Persistent Atrial Fibrillation Trial |
Figure 4‑234: AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment (ICE-AFIB) |
Figure 4‑235: FREEZE-AFIB Post-Market Study |
Figure 4‑236: Cryoballoon Pulmonary Vein Isolation as First Line Treatment for Typical Atrial Flutter |
Figure 4‑237: Ablation STrategies for Repeat PrOcedures in Patients With Atrial Fibrillation Recurrences (ASTRO AF) |
Figure 4‑238: ArcticLine Feasibility Study |
Figure 4‑239: A Prospective, Multicenter Investigation of the Adagio Cryoablation System in Patients With Atrial Fibrillation |
Figure 4‑240: A Prospective Study of Medical Therapy Against Cryoballoon Ablation in Symptomatic Recent Onset Persistent Atrial Fibrilation |
Figure 4‑241: STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation |
Figure 4‑242: A Comparison of Radiofrequency Catheter Ablation With or Without Contact-force and Cryoablation for Paroxysmal Atrial Fibrillation Ablation |
Figure 4‑243: A Prospective, Multicenter, Investigation of the Adagio PolarStar System in Subjects With Atrial Flutter |
Figure 4‑244: PV Cryoablation Efficacy Using Electrophysiological Endpoints and the New Generation ArticFont Advance ST Catheter (COR ADVANCE Study) |
Figure 4‑245: STOP Persistent AF |
Figure 4‑246: Cryoablation of Atrial Fibrillation in Patients With Severe Heart Failure |
Figure 4‑247: Left Atrial Cryoablation Enhanced by Ganglionated Plexi Ablation in the Treatment of Atrial Fibrillation |
Figure 4‑248: PV Cryoablation Efficacy Using Electrophysiological Endpoints and the New Generation ArticFont Advance ST Catheter (COR ADVANCE Study) |
Figure 4‑249: CardioFocus vs. Contact Force Guided Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation |
Figure 4‑250: Outcomes of Second-Generation Laser Balloon Ablation for Atrial Fibrillation (LIGHT-AF) |
Figure 4‑251: Laser Ablation Study for trEatment of atRial Fibrillation (LASER) |
Figure 5‑1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Global, 2018 – 2028 (US$M) |
Figure 5‑2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Region, Global, 2018 – 2028 (US$M) |
Figure 5‑3: Leading Competitors, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Global, 2021 (1 of 2) |
Figure 5‑4: Leading Competitors, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Global, 2021 (2 of 2) |
Figure 5‑5: SWOT Analysis, Abbott (1 of 2) |
Figure 5‑6: SWOT Analysis, Abbott (2 of 2) |
Figure 5‑7: SWOT Analysis, Biosense Webster (1 of 2) |
Figure 5‑8: SWOT Analysis, Biosense Webster (2 of 2) |
Figure 5‑9: SWOT Analysis, Biotronik (1 of 2) |
Figure 5‑10: SWOT Analysis, Biotronik (2 of 2) |
Figure 5‑11: SWOT Analysis, Boston Scientific (1 of 2) |
Figure 5‑12: SWOT Analysis, Boston Scientific (2 of 2) |
Figure 5‑13: SWOT Analysis, GE Healthcare (1 of 2) |
Figure 5‑14: SWOT Analysis, GE Healthcare (2 of 2) |
Figure 5‑15: SWOT Analysis, Medtronic (1 of 2) |
Figure 5‑16: SWOT Analysis, Medtronic (2 of 2) |
Figure 5‑17: SWOT Analysis, MicroPort (1 of 2) |
Figure 5‑18: SWOT Analysis, MicroPort (2 of 2) |
Figure 6‑1: Pacemaker Procedures Covered |
Figure 6‑2: Pacemaker Markets Covered |
Figure 6‑3: Pacemaker Regions Covered, Global (1 of 2) |
Figure 6‑4: Pacemaker Regions Covered, Global (2 of 2) |
Figure 6‑5: Pacemaker Placement Procedures by Segment, Global, 2018 – 2028 |
Figure 6‑6: Pacemaker Placement Procedures by Region, Global, 2018 – 2028 |
Figure 6‑7: Pacemaker Placement Procedures by Country, North America, 2018 – 2028 |
Figure 6‑8: Pacemaker Placement Procedures by Country, Latin America, 2018 – 2028 (1 of 2) |
Figure 6‑9: Pacemaker Placement Procedures by Country, Latin America, 2018 – 2028 (2 of 2) |
Figure 6‑10: Pacemaker Placement Procedures by Country, Western Europe, 2018 – 2028 |
Figure 6‑11: Pacemaker Placement Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2) |
Figure 6‑12: Pacemaker Placement Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2) |
Figure 6‑13: Pacemaker Placement Procedures by Country, Middle East, 2018 – 2028 |
Figure 6‑14: Pacemaker Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3) |
Figure 6‑15: Pacemaker Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3) |
Figure 6‑16: Pacemaker Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3) |
Figure 6‑17: Pacemaker Placement Procedures by Country, Africa, 2018 – 2028 |
Figure 6‑18: Initial Placement Pacemaker Procedures by Region, Global, 2018 – 2028 |
Figure 6‑19: Initial Placement Pacemaker Procedures by Country, North America, 2018 – 2028 |
Figure 6‑20: Initial Placement Pacemaker Procedures by Country, Latin America, 2018 – 2028 (1 of 2) |
Figure 6‑21: Initial Placement Pacemaker Procedures by Country, Latin America, 2018 – 2028 (2 of 2) |
Figure 6‑22: Initial Placement Pacemaker Procedures by Country, Western Europe, 2018 – 2028 |
Figure 6‑23: Initial Placement Pacemaker Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2) |
Figure 6‑24: Initial Placement Pacemaker Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2) |
Figure 6‑25: Initial Placement Pacemaker Procedures by Country, Middle East, 2018 – 2028 |
Figure 6‑26: Initial Placement Pacemaker Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3) |
Figure 6‑27: Initial Placement Pacemaker Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3) |
Figure 6‑28: Initial Placement Pacemaker Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3) |
Figure 6‑29: Initial Placement Pacemaker Procedures by Country, Africa, 2018 – 2028 |
Figure 6‑30: Replacement Pacemaker Procedures by Region, Global, 2018 – 2028 |
Figure 6‑31: Replacement Pacemaker Procedures by Country, North America, 2018 – 2028 |
Figure 6‑32: Replacement Pacemaker Procedures by Country, Latin America, 2018 – 2028 (1 of 2) |
Figure 6‑33: Replacement Pacemaker Procedures by Country, Latin America, 2018 – 2028 (2 of 2) |
Figure 6‑34: Replacement Pacemaker Procedures by Country, Western Europe, 2018 – 2028 |
Figure 6‑35: Replacement Pacemaker Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2) |
Figure 6‑36: Replacement Pacemaker Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2) |
Figure 6‑37: Replacement Pacemaker Procedures by Country, Middle East, 2018 – 2028 |
Figure 6‑38: Replacement Pacemaker Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3) |
Figure 6‑39: Replacement Pacemaker Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3) |
Figure 6‑40: Replacement Pacemaker Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3) |
Figure 6‑41: Replacement Pacemaker Procedures by Country, Africa, 2018 – 2028 |
Figure 6‑42: Pacemaker Market by Segment, Global, 2018 – 2028 (US$M) |
Figure 6‑43: Pacemaker Market by Region, Global, 2018 – 2028 (US$M) |
Figure 6‑44: Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑45: Units Sold by Region, Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑46: Average Selling Price by Region, Pacemaker Market, Global, 2018 – 2028 (US$) |
Figure 6‑47: Market Value by Region, Pacemaker Market, Global, 2018 – 2028 (US$M) |
Figure 6‑48: Single-Chamber Pacemaker Market by Segment, Global, 2018 – 2028 (US$M) |
Figure 6‑49: Single-Chamber Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑50: Units Sold by Region, Single-Chamber Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑51: Average Selling Price by Region, Single-Chamber Pacemaker Market, Global, 2018 – 2028 (US$) |
Figure 6‑52: Market Value by Region, Single-Chamber Pacemaker Market, Global, 2018 – 2028 (US$M) |
Figure 6‑53: Initial Placement Single-Chamber Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑54: Units Sold by Region, Initial Placement Single-Chamber Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑55: Average Selling Price by Region, Initial Placement Single-Chamber Pacemaker Market, Global, 2018 – 2028 (US$) |
Figure 6‑56: Market Value by Region, Initial Placement Single-Chamber Pacemaker Market, Global, 2018 – 2028 (US$M) |
Figure 6‑57: Replacement Single-Chamber Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑58: Units Sold by Region, Replacement Single-Chamber Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑59: Average Selling Price by Region, Replacement Single-Chamber Pacemaker Market, Global, 2018 – 2028 (US$) |
Figure 6‑60: Market Value by Region, Replacement Single-Chamber Pacemaker Market, Global, 2018 – 2028 (US$M) |
Figure 6‑61: Dual-Chamber Pacemaker Market by Segment, Global, 2018 – 2028 (US$M) |
Figure 6‑62: Dual-Chamber Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑63: Units Sold by Region, Dual-Chamber Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑64: Average Selling Price by Region, Dual-Chamber Pacemaker Market, Global, 2018 – 2028 (US$) |
Figure 6‑65: Market Value by Region, Dual-Chamber Pacemaker Market, Global, 2018 – 2028 (US$M) |
Figure 6‑66: Initial Placement Dual-Chamber Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑67: Units Sold by Region, Initial Placement Dual-Chamber Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑68: Average Selling Price by Region, Initial Placement Dual-Chamber Pacemaker Market, Global, 2018 – 2028 (US$) |
Figure 6‑69: Market Value by Region, Initial Placement Dual-Chamber Pacemaker Market, Global, 2018 – 2028 (US$M) |
Figure 6‑70: Replacement Dual-Chamber Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑71: Units Sold by Region, Replacement Dual-Chamber Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑72: Average Selling Price by Region, Replacement Dual-Chamber Pacemaker Market, Global, 2018 – 2028 (US$) |
Figure 6‑73: Market Value by Region, Replacement Dual-Chamber Pacemaker Market, Global, 2018 – 2028 (US$M) |
Figure 6‑74: Leadless Pacemaker Market by Segment, Global, 2018 – 2028 (US$M) |
Figure 6‑75: Leadless Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑76: Units Sold by Region, Leadless Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑77: Average Selling Price by Region, Leadless Pacemaker Market, Global, 2018 – 2028 (US$) |
Figure 6‑78: Market Value by Region, Leadless Pacemaker Market, Global, 2018 – 2028 (US$M) |
Figure 6‑79: Initial Placement Leadless Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑80: Units Sold by Region, Initial Placement Leadless Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑81: Average Selling Price by Region, Initial Placement Leadless Pacemaker Market, Global, 2018 – 2028 (US$) |
Figure 6‑82: Market Value by Region, Initial Placement Leadless Pacemaker Market, Global, 2018 – 2028 (US$M) |
Figure 6‑83: Replacement Leadless Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑84: Units Sold by Region, Replacement Leadless Pacemaker Market, Global, 2018 – 2028 |
Figure 6‑85: Average Selling Price by Region, Replacement Leadless Pacemaker Market, Global, 2018 – 2028 (US$) |
Figure 6‑86: Market Value by Region, Replacement Leadless Pacemaker Market, Global, 2018 – 2028 (US$M) |
Figure 6‑87: Leading Competitors, Pacemaker Market, Global, 2021 |
Figure 6‑88: Leading Competitors by Region, Pacemaker Market, Global, 2021 |
Figure 6‑89: Leading Competitors by Region, Single-Chamber Pacemaker Market, Global, 2021 |
Figure 6‑90: Leading Competitors by Region, Dual-Chamber Pacemaker Market, Global, 2021 |
Figure 7‑1: ICD Procedures Covered |
Figure 7‑2: ICD Markets Covered |
Figure 7‑3: ICD Regions Covered, Global (1 of 2) |
Figure 7‑4: ICD Regions Covered, Global (2 of 2) |
Figure 7‑5: ICD Placement Procedures by Segment, Global, 2018 – 2028 |
Figure 7‑6: ICD Placement Procedures by Region, Global, 2018 – 2028 |
Figure 7‑7: ICD Placement Procedures by Country, North America, 2018 – 2028 |
Figure 7‑8: ICD Placement Procedures by Country, Latin America, 2018 – 2028 (1 of 2) |
Figure 7‑9: ICD Placement Procedures by Country, Latin America, 2018 – 2028 (2 of 2) |
Figure 7‑10: ICD Placement Procedures by Country, Western Europe, 2018 – 2028 |
Figure 7‑11: ICD Placement Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2) |
Figure 7‑12: ICD Placement Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2) |
Figure 7‑13: ICD Placement Procedures by Country, Middle East, 2018 – 2028 |
Figure 7‑14: ICD Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3) |
Figure 7‑15: ICD Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3) |
Figure 7‑16: ICD Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3) |
Figure 7‑17: ICD Placement Procedures by Country, Africa, 2018 – 2028 |
Figure 7‑18: Initial Placement ICD Procedures by Region, Global, 2018 – 2028 |
Figure 7‑19: Initial Placement ICD Procedures by Country, North America, 2018 – 2028 |
Figure 7‑20: Initial Placement ICD Procedures by Country, Latin America, 2018 – 2028 (1 of 2) |
Figure 7‑21: Initial Placement ICD Procedures by Country, Latin America, 2018 – 2028 (2 of 2) |
Figure 7‑22: Initial Placement ICD Procedures by Country, Western Europe, 2018 – 2028 |
Figure 7‑23: Initial Placement ICD Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2) |
Figure 7‑24: Initial Placement ICD Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2) |
Figure 7‑25: Initial Placement ICD Procedures by Country, Middle East, 2018 – 2028 |
Figure 7‑26: Initial Placement ICD Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3) |
Figure 7‑27: Initial Placement ICD Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3) |
Figure 7‑28: Initial Placement ICD Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3) |
Figure 7‑29: Initial Placement ICD Procedures by Country, Africa, 2018 – 2028 |
Figure 7‑30: Replacement ICD Procedures by Region, Global, 2018 – 2028 |
Figure 7‑31: Replacement ICD Procedures by Country, North America, 2018 – 2028 |
Figure 7‑32: Replacement ICD Procedures by Country, Latin America, 2018 – 2028 (1 of 2) |
Figure 7‑33: Replacement ICD Procedures by Country, Latin America, 2018 – 2028 (2 of 2) |
Figure 7‑34: Replacement ICD Procedures by Country, Western Europe, 2018 – 2028 |
Figure 7‑35: Replacement ICD Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2) |
Figure 7‑36: Replacement ICD Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2) |
Figure 7‑37: Replacement ICD Procedures by Country, Middle East, 2018 – 2028 |
Figure 7‑38: Replacement ICD Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3) |
Figure 7‑39: Replacement ICD Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3) |
Figure 7‑40: Replacement ICD Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3) |
Figure 7‑41: Replacement ICD Procedures by Country, Africa, 2018 – 2028 |
Figure 7‑42: ICD Market by Segment, Global, 2018 – 2028 (US$M) |
Figure 7‑43: ICD Market by Region, Global, 2018 – 2028 (US$M) |
Figure 7‑44: ICD Market, Global, 2018 – 2028 |
Figure 7‑45: Units Sold by Region, ICD Market, Global, 2018 – 2028 |
Figure 7‑46: Average Selling Price by Region, ICD Market, Global, 2018 – 2028 (US$) |
Figure 7‑47: Market Value by Region, ICD Market, Global, 2018 – 2028 (US$M) |
Figure 7‑48: Single-Chamber ICD Market by Segment, Global, 2018 – 2028 (US$M) |
Figure 7‑49: Single-Chamber ICD Market, Global, 2018 – 2028 |
Figure 7‑50: Units Sold by Region, Single-Chamber ICD Market, Global, 2018 – 2028 |
Figure 7‑51: Average Selling Price by Region, Single-Chamber ICD Market, Global, 2018 – 2028 (US$) |
Figure 7‑52: Market Value by Region, Single-Chamber ICD Market, Global, 2018 – 2028 (US$M) |
Figure 7‑53: Initial Placement Single-Chamber ICD Market, Global, 2018 – 2028 |
Figure 7‑54: Units Sold by Region, Initial Placement Single-Chamber ICD Market, Global, 2018 – 2028 |
Figure 7‑55: Average Selling Price by Region, Initial Placement Single-Chamber ICD Market, Global, 2018 – 2028 (US$) |
Figure 7‑56: Market Value by Region, Initial Placement Single-Chamber ICD Market, Global, 2018 – 2028 (US$M) |
Figure 7‑57: Replacement Single-Chamber ICD Market, Global, 2018 – 2028 |
Figure 7‑58: Units Sold by Region, Replacement Single-Chamber ICD Market, Global, 2018 – 2028 |
Figure 7‑59: Average Selling Price by Region, Replacement Single-Chamber ICD Market, Global, 2018 – 2028 (US$) |
Figure 7‑60: Market Value by Region, Replacement Single-Chamber ICD Market, Global, 2018 – 2028 (US$M) |
Figure 7‑61: Dual-Chamber ICD Market by Segment, Global, 2018 – 2028 (US$M) |
Figure 7‑62: Dual-Chamber ICD Market, Global, 2018 – 2028 |
Figure 7‑63: Units Sold by Region, Dual-Chamber ICD Market, Global, 2018 – 2028 |
Figure 7‑64: Average Selling Price by Region, Dual-Chamber ICD Market, Global, 2018 – 2028 (US$) |
Figure 7‑65: Market Value by Region, Dual-Chamber ICD Market, Global, 2018 – 2028 (US$M) |
Figure 7‑66: Initial Placement Dual-Chamber ICD Market, Global, 2018 – 2028 |
Figure 7‑67: Units Sold by Region, Initial Placement Dual-Chamber ICD Market, Global, 2018 – 2028 |
Figure 7‑68: Average Selling Price by Region, Initial Placement Dual-Chamber ICD Market, Global, 2018 – 2028 (US$) |
Figure 7‑69: Market Value by Region, Initial Placement Dual-Chamber ICD Market, Global, 2018 – 2028 (US$M) |
Figure 7‑70: Replacement Dual-Chamber ICD Market, Global, 2018 – 2028 |
Figure 7‑71: Units Sold by Region, Replacement Dual-Chamber ICD Market, Global, 2018 – 2028 |
Figure 7‑72: Average Selling Price by Region, Replacement Dual-Chamber ICD Market, Global, 2018 – 2028 (US$) |
Figure 7‑73: Market Value by Region, Replacement Dual-Chamber ICD Market, Global, 2018 – 2028 (US$M) |
Figure 7‑74: S-ICD Market by Segment, Global, 2018 – 2028 (US$M) |
Figure 7‑75: S-ICD Market, Global, 2018 – 2028 |
Figure 7‑76: Units Sold by Region, S-ICD Market, Global, 2018 – 2028 |
Figure 7‑77: Average Selling Price by Region, S-ICD Market, Global, 2018 – 2028 (US$) |
Figure 7‑78: Market Value by Region, S-ICD Market, Global, 2018 – 2028 (US$M) |
Figure 7‑79: Initial Placement S-ICD Market, Global, 2018 – 2028 |
Figure 7‑80: Units Sold by Region, Initial Placement S-ICD Market, Global, 2018 – 2028 |
Figure 7‑81: Average Selling Price by Region, Initial Placement S-ICD Market, Global, 2018 – 2028 (US$) |
Figure 7‑82: Market Value by Region, Initial Placement S-ICD Market, Global, 2018 – 2028 (US$M) |
Figure 7‑83: Replacement S-ICD Market, Global, 2018 – 2028 |
Figure 7‑84: Units Sold by Region, Replacement S-ICD Market, Global, 2018 – 2028 |
Figure 7‑85: Average Selling Price by Region, Replacement S-ICD Market, Global, 2018 – 2028 (US$) |
Figure 7‑86: Market Value by Region, Replacement S-ICD Market, Global, 2018 – 2028 (US$M) |
Figure 7‑87: Leading Competitors, ICD Market, Global, 2021 |
Figure 7‑88: Leading Competitors by Region, ICD Market, Global, 2021 |
Figure 7‑89: Leading Competitors by Region, Single-Chamber ICD Market, Global, 2021 |
Figure 7‑90: Leading Competitors by Region, Dual-Chamber ICD Market, Global, 2021 |
Figure 8‑1: CRT Device Procedures Covered |
Figure 8‑2: CRT Device Markets Covered |
Figure 8‑3: CRT Device Regions Covered, Global (1 of 2) |
Figure 8‑4: CRT Device Regions Covered, Global (2 of 2) |
Figure 8‑5: CRT Placement Procedures by Segment, Global, 2018 – 2028 |
Figure 8‑6: CRT Placement Procedures by Region, Global, 2018 – 2028 |
Figure 8‑7: CRT Placement Procedures by Country, North America, 2018 – 2028 |
Figure 8‑8: CRT Placement Procedures by Country, Latin America, 2018 – 2028 (1 of 2) |
Figure 8‑9: CRT Placement Procedures by Country, Latin America, 2018 – 2028 (2 of 2) |
Figure 8‑10: CRT Placement Procedures by Country, Western Europe, 2018 – 2028 |
Figure 8‑11: CRT Placement Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2) |
Figure 8‑12: CRT Placement Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2) |
Figure 8‑13: CRT Placement Procedures by Country, Middle East, 2018 – 2028 |
Figure 8‑14: CRT Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3) |
Figure 8‑15: CRT Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3) |
Figure 8‑16: CRT Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3) |
Figure 8‑17: CRT Placement Procedures by Country, Africa, 2018 – 2028 |
Figure 8‑18: Initial Placement CRT Procedures by Region, Global, 2018 – 2028 |
Figure 8‑19: Initial Placement CRT Procedures by Country, North America, 2018 – 2028 |
Figure 8‑20: Initial Placement CRT Procedures by Country, Latin America, 2018 – 2028 (1 of 2) |
Figure 8‑21: Initial Placement CRT Procedures by Country, Latin America, 2018 – 2028 (2 of 2) |
Figure 8‑22: Initial Placement CRT Procedures by Country, Western Europe, 2018 – 2028 |
Figure 8‑23: Initial Placement CRT Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2) |
Figure 8‑24: Initial Placement CRT Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2) |
Figure 8‑25: Initial Placement CRT Procedures by Country, Middle East, 2018 – 2028 |
Figure 8‑26: Initial Placement CRT Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3) |
Figure 8‑27: Initial Placement CRT Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3) |
Figure 8‑28: Initial Placement CRT Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3) |
Figure 8‑29: Initial Placement CRT Procedures by Country, Africa, 2018 – 2028 |
Figure 8‑30: Replacement CRT Procedures by Region, Global, 2018 – 2028 |
Figure 8‑31: Replacement CRT Procedures by Country, North America, 2018 – 2028 |
Figure 8‑32: Replacement CRT Procedures by Country, Latin America, 2018 – 2028 (1 of 2) |
Figure 8‑33: Replacement CRT Procedures by Country, Latin America, 2018 – 2028 (2 of 2) |
Figure 8‑34: Replacement CRT Procedures by Country, Western Europe, 2018 – 2028 |
Figure 8‑35: Replacement CRT Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2) |
Figure 8‑36: Replacement CRT Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2) |
Figure 8‑37: Replacement CRT Procedures by Country, Middle East, 2018 – 2028 |
Figure 8‑38: Replacement CRT Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3) |
Figure 8‑39: Replacement CRT Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3) |
Figure 8‑40: Replacement CRT Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3) |
Figure 8‑41: Replacement CRT Procedures by Country, Africa, 2018 – 2028 |
Figure 8‑42: CRT Device Market by Segment, Global, 2018 – 2028 (US$M) |
Figure 8‑43: CRT Device Market by Region, Global, 2018 – 2028 (US$M) |
Figure 8‑44: CRT Device Market, Global, 2018 – 2028 |
Figure 8‑45: Units Sold by Region, CRT Device Market, Global, 2018 – 2028 |
Figure 8‑46: Average Selling Price by Region, CRT Device Market, Global, 2018 – 2028 (US$) |
Figure 8‑47: Market Value by Region, CRT Device Market, Global, 2018 – 2028 (US$M) |
Figure 8‑48: CRT-P Market by Segment, Global, 2018 – 2028 (US$M) |
Figure 8‑49: CRT-P Market, Global, 2018 – 2028 |
Figure 8‑50: Units Sold by Region, CRT-P Market, Global, 2018 – 2028 |
Figure 8‑51: Average Selling Price by Region, CRT-P Market, Global, 2018 – 2028 (US$) |
Figure 8‑52: Market Value by Region, CRT-P Market, Global, 2018 – 2028 (US$M) |
Figure 8‑53: Initial Placement CRT-P Market, Global, 2018 – 2028 |
Figure 8‑54: Units Sold by Region, Initial Placement CRT-P Market, Global, 2018 – 2028 |
Figure 8‑55: Average Selling Price by Region, Initial Placement CRT-P Market, Global, 2018 – 2028 (US$) |
Figure 8‑56: Market Value by Region, Initial Placement CRT-P Market, Global, 2018 – 2028 (US$M) |
Figure 8‑57: Replacement CRT-P Market, Global, 2018 – 2028 |
Figure 8‑58: Units Sold by Region, Replacement CRT-P Market, Global, 2018 – 2028 |
Figure 8‑59: Average Selling Price by Region, Replacement CRT-P Market, Global, 2018 – 2028 (US$) |
Figure 8‑60: Market Value by Region, Replacement CRT-P Market, Global, 2018 – 2028 (US$M) |
Figure 8‑61: CRT-D Market by Segment, Global, 2018 – 2028 (US$M) |
Figure 8‑62: CRT-D Market, Global, 2018 – 2028 |
Figure 8‑63: Units Sold by Region, CRT-D Market, Global, 2018 – 2028 |
Figure 8‑64: Average Selling Price by Region, CRT-D Market, Global, 2018 – 2028 (US$) |
Figure 8‑65: Market Value by Region, CRT-D Market, Global, 2018 – 2028 (US$M) |
Figure 8‑66: Initial Placement CRT-D Market, Global, 2018 – 2028 |
Figure 8‑67: Units Sold by Region, Initial Placement CRT-D Market, Global, 2018 – 2028 |
Figure 8‑68: Average Selling Price by Region, Initial Placement CRT-D Market, Global, 2018 – 2028 (US$) |
Figure 8‑69: Market Value by Region, Initial Placement CRT-D Market, Global, 2018 – 2028 (US$M) |
Figure 8‑70: Replacement CRT-D Market, Global, 2018 – 2028 |
Figure 8‑71: Units Sold by Region, Replacement CRT-D Market, Global, 2018 – 2028 |
Figure 8‑72: Average Selling Price by Region, Replacement CRT-D Market, Global, 2018 – 2028 (US$) |
Figure 8‑73: Market Value by Region, Replacement CRT-D Market, Global, 2018 – 2028 (US$M) |
Figure 8‑74: Leading Competitors, CRT Device Market, Global, 2021 |
Figure 8‑75: Leading Competitors by Region, CRT Device Market, Global, 2021 |
Figure 8‑76: Leading Competitors by Region, CRT-P Market, Global, 2021 |
Figure 8‑77: Leading Competitors by Region, CRT-DMarket, Global, 2021 |
Figure 9‑1: Cardiac Lead Markets Covered |
Figure 9‑2: Cardiac Lead Regions Covered, Global (1 of 2) |
Figure 9‑3: Cardiac Lead Regions Covered, Global (2 of 2) |
Figure 9‑4: Cardiac Lead Market by Segment, Global, 2018 – 2028 (US$M) |
Figure 9‑5: Cardiac Lead Market by Region, Global, 2018 – 2028 (US$M) |
Figure 9‑6: Cardiac Lead Market, Global, 2018 – 2028 |
Figure 9‑7: Units Sold by Region, Cardiac Lead Market, Global, 2018 – 2028 |
Figure 9‑8: Average Selling Price by Region, Cardiac Lead Market, Global, 2018 – 2028 (US$) |
Figure 9‑9: Market Value by Region, Cardiac Lead Market, Global, 2018 – 2028 (US$M) |
Figure 9‑10: Pacing Lead Market, Global, 2018 – 2028 |
Figure 9‑11: Units Sold by Region, Pacing Lead Market, Global, 2018 – 2028 |
Figure 9‑12: Average Selling Price by Region, Pacing Lead Market, Global, 2018 – 2028 (US$) |
Figure 9‑13: Market Value by Region, Pacing Lead Market, Global, 2018 – 2028 (US$M) |
Figure 9‑14: Defibrillation Lead Market, Global, 2018 – 2028 |
Figure 9‑15: Units Sold by Region, Defibrillation Lead Market, Global, 2018 – 2028 |
Figure 9‑16: Average Selling Price by Region, Defibrillation Lead Market, Global, 2018 – 2028 (US$) |
Figure 9‑17: Market Value by Region, Defibrillation Lead Market, Global, 2018 – 2028 (US$M) |
Figure 9‑18: LV Lead Market, Global, 2018 – 2028 |
Figure 9‑19: Units Sold by Region, LV Lead Market, Global, 2018 – 2028 |
Figure 9‑20: Average Selling Price by Region, LV Lead Market, Global, 2018 – 2028 (US$) |
Figure 9‑21: Market Value by Region, LV Lead Market, Global, 2018 – 2028 (US$M) |
Figure 9‑22: Leading Competitors, Cardiac Lead Market, Global, 2021 |
Figure 9‑23: Leading Competitors by Region, Cardiac Lead Market, Global, 2021 |
Figure 9‑24: Leading Competitors by Region, Pacing Lead Market, Global, 2021 |
Figure 9‑25: Leading Competitors by Region, Defibrillation Lead Market, Global, 2021 |
Figure 9‑26: Leading Competitors by Region, LV Lead Market, Global, 2021 |
Figure 10‑1: Implantable Loop Recorder Regions Covered, Global (1 of 2) |
Figure 10‑2: Implantable Loop Recorder Regions Covered, Global (2 of 2) |
Figure 10‑3: Implantable Loop Recorder Placement Procedures by Region, Global, 2018 – 2028 |
Figure 10‑4: Implantable Loop Recorder Placement Procedures by Country, North America, 2018 – 2028 |
Figure 10‑5: Implantable Loop Recorder Placement Procedures by Country, Latin America, 2018 – 2028 (1 of 2) |
Figure 10‑6: Implantable Loop Recorder Placement Procedures by Country, Latin America, 2018 – 2028 (2 of 2) |
Figure 10‑7: Implantable Loop Recorder Placement Procedures by Country, Western Europe, 2018 – 2028 |
Figure 10‑8: Implantable Loop Recorder Placement Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2) |
Figure 10‑9: Implantable Loop Recorder Placement Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2) |
Figure 10‑10: Implantable Loop Recorder Placement Procedures by Country, Middle East, 2018 – 2028 |
Figure 10‑11: Implantable Loop Recorder Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3) |
Figure 10‑12: Implantable Loop Recorder Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3) |
Figure 10‑13: Implantable Loop Recorder Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3) |
Figure 10‑14: Implantable Loop Recorder Placement Procedures by Country, Africa, 2018 – 2028 |
Figure 10‑15: Implantable Loop Recorder Market, Global, 2018 – 2028 |
Figure 10‑16: Units Sold by Region, Implantable Loop Recorder Market, Global, 2018 – 2028 |
Figure 10‑17: Average Selling Price by Region, Implantable Loop Recorder Market, Global, 2018 – 2028 (US$) |
Figure 10‑18: Market Value by Region, Implantable Loop Recorder Market, Global, 2018 – 2028 (US$M) |
Figure 10‑19: Leading Competitors, Implantable Loop Recorder Market, Global, 2021 |
Figure 11‑1: Electrophysiology Lab System Markets Covered |
Figure 11‑2: Electrophysiology Lab System Regions Covered, Global (1 of 2) |
Figure 11‑3: Electrophysiology Lab System Regions Covered, Global (2 of 2) |
Figure 11‑4: Electrophysiology Lab System Market by Segment, Global, 2018 – 2028 (US$M) |
Figure 11‑5: Electrophysiology Lab System Market by Region, Global, 2018 – 2028 (US$M) |
Figure 11‑6: Electrophysiology Lab System Market, Global, 2018 – 2028 |
Figure 11‑7: Units Sold by Region, Electrophysiology Lab System Market, Global, 2018 – 2028 |
Figure 11‑8: Average Selling Price by Region, Electrophysiology Lab System Market, Global, 2018 – 2028 (US$) |
Figure 11‑9: Market Value by Region, Electrophysiology Lab System Market, Global, 2018 – 2028 (US$M) |
Figure 11‑10: 3D Mapping System Market, Global, 2018 – 2028 |
Figure 11‑11: Units Sold by Region, 3D Mapping System Market, Global, 2018 – 2028 |
Figure 11‑12: Average Selling Price by Region, 3D Mapping System Market, Global, 2018 – 2028 (US$) |
Figure 11‑13: Market Value by Region, 3D Mapping System Market, Global, 2018 – 2028 (US$M) |
Figure 11‑14: EP Recording System Market, Global, 2018 – 2028 |
Figure 11‑15: Units Sold by Region, EP Recording System Market, Global, 2018 – 2028 |
Figure 11‑16: Average Selling Price by Region, EP Recording System Market, Global, 2018 – 2028 (US$) |
Figure 11‑17: Market Value by Region, EP Recording System Market, Global, 2018 – 2028 (US$M) |
Figure 11‑18: Leading Competitors, Electrophysiology Lab System Market, Global, 2021 |
Figure 12‑1: Diagnostic Electrophysiology Catheter Markets Covered |
Figure 12‑2: Diagnostic Electrophysiology Catheter Regions Covered, Global (1 of 2) |
Figure 12‑3: Diagnostic Electrophysiology Catheter Regions Covered, Global (2 of 2) |
Figure 12‑4: Diagnostic Electrophysiology Procedures by Region, Global, 2018 – 2028 |
Figure 12‑5: Diagnostic Electrophysiology Procedures by Country, North America, 2018 – 2028 |
Figure 12‑6: Diagnostic Electrophysiology Procedures by Country, Latin America, 2018 – 2028 (1 of 2) |
Figure 12‑7: Diagnostic Electrophysiology Procedures by Country, Latin America, 2018 – 2028 (2 of 2) |
Figure 12‑8: Diagnostic Electrophysiology Procedures by Country, Western Europe, 2018 – 2028 |
Figure 12‑9: Diagnostic Electrophysiology Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2) |
Figure 12‑10: Diagnostic Electrophysiology Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2) |
Figure 12‑11: Diagnostic Electrophysiology Procedures by Country, Middle East, 2018 – 2028 |
Figure 12‑12: Diagnostic Electrophysiology Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3) |
Figure 12‑13: Diagnostic Electrophysiology Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3) |
Figure 12‑14: Diagnostic Electrophysiology Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3) |
Figure 12‑15: Diagnostic Electrophysiology Procedures by Country, Africa, 2018 – 2028 |
Figure 12‑16: Diagnostic Electrophysiology Catheter Market by Segment, Global, 2018 – 2028 (US$M) |
Figure 12‑17: Diagnostic Electrophysiology Catheter Market by Region, Global, 2018 – 2028 (US$M) |
Figure 12‑18: Diagnostic Electrophysiology Catheter Market, Global, 2018 – 2028 |
Figure 12‑19: Units Sold by Region, Diagnostic Electrophysiology Catheter Market, Global, 2018 – 2028 |
Figure 12‑20: Average Selling Price by Region, Diagnostic Electrophysiology Catheter Market, Global, 2018 – 2028 (US$) |
Figure 12‑21: Market Value by Region, Diagnostic Electrophysiology Catheter Market, Global, 2018 – 2028 (US$M) |
Figure 12‑22: Conventional Electrophysiology Catheter Market, Global, 2018 – 2028 |
Figure 12‑23: Units Sold by Region, Conventional Electrophysiology Catheter Market, Global, 2018 – 2028 |
Figure 12‑24: Average Selling Price by Region, Conventional Electrophysiology Catheter Market, Global, 2018 – 2028 (US$) |
Figure 12‑25: Market Value by Region, Conventional Electrophysiology Catheter Market, Global, 2018 – 2028 (US$M) |
Figure 12‑26: Advanced Electrophysiology Catheter Market, Global, 2018 – 2028 |
Figure 12‑27: Units Sold by Region, Advanced Electrophysiology Catheter Market, Global, 2018 – 2028 |
Figure 12‑28: Average Selling Price by Region, Advanced Electrophysiology Catheter Market, Global, 2018 – 2028 (US$) |
Figure 12‑29: Market Value by Region, Advanced Electrophysiology Catheter Market, Global, 2018 – 2028 (US$M) |
Figure 12‑30: ICE Catheter Market, Global, 2018 – 2028 |
Figure 12‑31: Units Sold by Region, ICE Catheter Market, Global, 2018 – 2028 |
Figure 12‑32: Average Selling Price by Region, ICE Catheter Market, Global, 2018 – 2028 (US$) |
Figure 12‑33: Market Value by Region, ICE Catheter Market, Global, 2018 – 2028 (US$M) |
Figure 12‑34: Leading Competitors, Diagnostic Electrophysiology Catheter Market, Global, 2021 |
Figure 13‑1: Cardiac Ablation Catheter Procedures Covered |
Figure 13‑2: Cardiac Ablation Catheter Markets Covered |
Figure 13‑3: Cardiac Ablation Catheter Regions Covered, Global (1 of 2) |
Figure 13‑4: Cardiac Ablation Catheter Regions Covered, Global (2 of 2) |
Figure 13‑5: Cardiac Ablation Procedures by Segment, Global, 2018 – 2028 |
Figure 13‑6: Cardiac Ablation Procedures by Region, Global, 2018 – 2028 |
Figure 13‑7: Cardiac Ablation Procedures by Country, North America, 2018 – 2028 |
Figure 13‑8: Cardiac Ablation Procedures by Country, Latin America, 2018 – 2028 (1 of 2) |
Figure 13‑9: Cardiac Ablation Procedures by Country, Latin America, 2018 – 2028 (2 of 2) |
Figure 13‑10: Cardiac Ablation Procedures by Country, Western Europe, 2018 – 2028 |
Figure 13‑11: Cardiac Ablation Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2) |
Figure 13‑12: Cardiac Ablation Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2) |
Figure 13‑13: Cardiac Ablation Procedures by Country, Middle East, 2018 – 2028 |
Figure 13‑14: Cardiac Ablation Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3) |
Figure 13‑15: Cardiac Ablation Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3) |
Figure 13‑16: Cardiac Ablation Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3) |
Figure 13‑17: Cardiac Ablation Procedures by Country, Africa, 2018 – 2028 |
Figure 13‑18: RF Ablation Procedures by Region, Global, 2018 – 2028 |
Figure 13‑19: RF Ablation Procedures by Country, North America, 2018 – 2028 |
Figure 13‑20: RF Ablation Procedures by Country, Latin America, 2018 – 2028 (1 of 2) |
Figure 13‑21: RF Ablation Procedures by Country, Latin America, 2018 – 2028 (2 of 2) |
Figure 13‑22: RF Ablation Procedures by Country, Western Europe, 2018 – 2028 |
Figure 13‑23: RF Ablation Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2) |
Figure 13‑24: RF Ablation Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2) |
Figure 13‑25: RF Ablation Procedures by Country, Middle East, 2018 – 2028 |
Figure 13‑26: RF Ablation Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3) |
Figure 13‑27: RF Ablation Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3) |
Figure 13‑28: RF Ablation Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3) |
Figure 13‑29: RF Ablation Procedures by Country, Africa, 2018 – 2028 |
Figure 13‑30: Cryoablation Procedures by Region, Global, 2018 – 2028 |
Figure 13‑31: Cryoablation Procedures by Country, North America, 2018 – 2028 |
Figure 13‑32: Cryoablation Procedures by Country, Latin America, 2018 – 2028 (1 of 2) |
Figure 13‑33: Cryoablation Procedures by Country, Latin America, 2018 – 2028 (2 of 2) |
Figure 13‑34: Cryoablation Procedures by Country, Western Europe, 2018 – 2028 |
Figure 13‑35: Cryoablation Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2) |
Figure 13‑36: Cryoablation Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2) |
Figure 13‑37: Cryoablation Procedures by Country, Middle East, 2018 – 2028 |
Figure 13‑38: Cryoablation Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3) |
Figure 13‑39: Cryoablation Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3) |
Figure 13‑40: Cryoablation Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3) |
Figure 13‑41: Cryoablation Procedures by Country, Africa, 2018 – 2028 |
Figure 13‑42: Cardiac Ablation Catheter Market by Segment, Global, 2018 – 2028 (US$M) |
Figure 13‑43: Cardiac Ablation Catheter Market by Region, Global, 2018 – 2028 (US$M) |
Figure 13‑44: Cardiac Ablation Catheter Market, Global, 2018 – 2028 |
Figure 13‑45: Units Sold by Region, Cardiac Ablation Catheter Market, Global, 2018 – 2028 |
Figure 13‑46: Average Selling Price by Region, Cardiac Ablation Catheter Market, Global, 2018 – 2028 (US$) |
Figure 13‑47: Market Value by Region, Cardiac Ablation Catheter Market, Global, 2018 – 2028 (US$M) |
Figure 13‑48: RF Ablation Catheter Market, Global, 2018 – 2028 |
Figure 13‑49: Units Sold by Region, RF Ablation Catheter Market, Global, 2018 – 2028 |
Figure 13‑50: Average Selling Price by Region, RF Ablation Catheter Market, Global, 2018 – 2028 (US$) |
Figure 13‑51: Market Value by Region, RF Ablation Catheter Market, Global, 2018 – 2028 (US$M) |
Figure 13‑52: Cryoablation Catheter Market, Global, 2018 – 2028 |
Figure 13‑53: Units Sold by Region, Cryoablation Catheter Market, Global, 2018 – 2028 |
Figure 13‑54: Average Selling Price by Region, Cryoablation Catheter Market, Global, 2018 – 2028 (US$) |
Figure 13‑55: Market Value by Region, Cryoablation Catheter Market, Global, 2018 – 2028 (US$M) |
Figure 13‑56: Leading Competitors, Cardiac Ablation Catheter Market, Global, 2021 |
Figure 13‑57: Leading Competitors by Region, Cardiac Ablation Catheter Market, Global, 2021 |
Figure 13‑58: Leading Competitors by Region, RF Ablation Catheter Market, Global, 2021 |